Developability Assessment and Optimization of Antibodies and Antibody-derived Molecules at Early-Stage Discovery
Weijie Zhang, Nan Feng, Shuang Wang, Hang Zhou, Jianqing Xu, Jijie Gu and Zhuozhi Wang
Although the safety and efficacy of a drug candidate are evaluated by sponsors and regulatory agencies, many aspects of developability of a given antibody candidate during early drug R&D are sometimes overlooked. In this poster, we outline our novel criterion of developability and general developability screening process during the early discovery stage of antibody-derived therapeutics.
This scientific poster was originally presented during the Festival of Biologics 2023 conference